DD232822A5 - Verfahren zur herstellung eines viruspraeparates gegen die mareksche gefluegelkrankheit - Google Patents

Verfahren zur herstellung eines viruspraeparates gegen die mareksche gefluegelkrankheit Download PDF

Info

Publication number
DD232822A5
DD232822A5 DD85274954A DD27495485A DD232822A5 DD 232822 A5 DD232822 A5 DD 232822A5 DD 85274954 A DD85274954 A DD 85274954A DD 27495485 A DD27495485 A DD 27495485A DD 232822 A5 DD232822 A5 DD 232822A5
Authority
DD
German Democratic Republic
Prior art keywords
clone
virus
mdv
marek
disease
Prior art date
Application number
DD85274954A
Other languages
German (de)
English (en)
Inventor
Gerbe F De Boer
Original Assignee
Centraal Diergeneeskundig Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centraal Diergeneeskundig Inst filed Critical Centraal Diergeneeskundig Inst
Publication of DD232822A5 publication Critical patent/DD232822A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DD85274954A 1984-04-09 1985-04-08 Verfahren zur herstellung eines viruspraeparates gegen die mareksche gefluegelkrankheit DD232822A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8401120A NL8401120A (nl) 1984-04-09 1984-04-09 Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek.

Publications (1)

Publication Number Publication Date
DD232822A5 true DD232822A5 (de) 1986-02-12

Family

ID=19843774

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85274954A DD232822A5 (de) 1984-04-09 1985-04-08 Verfahren zur herstellung eines viruspraeparates gegen die mareksche gefluegelkrankheit

Country Status (17)

Country Link
US (1) US4673572A (es)
EP (1) EP0159743B1 (es)
JP (1) JPS6123A (es)
AT (1) ATE56364T1 (es)
AU (1) AU574164B2 (es)
CA (1) CA1251397A (es)
DD (1) DD232822A5 (es)
DE (1) DE3579617D1 (es)
ES (1) ES8605680A1 (es)
HU (1) HU194496B (es)
IL (1) IL74809A (es)
IN (1) IN163229B (es)
MX (1) MX7718E (es)
NL (1) NL8401120A (es)
WO (1) WO1985004588A1 (es)
YU (1) YU44687B (es)
ZA (1) ZA852564B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456101A (en) * 1980-11-08 1984-06-26 Honda Giken Kogyo Kabushiki Kaisha Vehicular brake operating system
JP2508625B2 (ja) * 1985-08-30 1996-06-19 ソニー株式会社 半導体レ−ザ−
FR2598596B1 (fr) * 1986-05-15 1990-10-19 Sanofi Elf Bio Ind Procede de traitement du lait en vue de l'obtention de fromages
US5849299A (en) * 1991-06-28 1998-12-15 The United States Of America As Represented By The Secretary Of Agriculture Attenuated revertant serotype 1 marek's disease vaccine
WO1993023078A1 (en) * 1992-05-19 1993-11-25 Viktoria Alexeevna Lukina Vaccine for prophylaxis of marek disease of birds and method of its preparation
IL114501A (en) * 1994-07-14 1999-08-17 Akzo Nobel Nv Marek's disease virus vaccine
EP0703294A1 (en) * 1994-07-14 1996-03-27 Akzo Nobel N.V. Marek's disease virus vaccine
EP0748867A1 (en) * 1995-06-12 1996-12-18 Duphar International Research B.V Marek's disease vaccine
US5989805A (en) * 1995-10-27 1999-11-23 Board Of Trustees Operating Michigan State University Immortal avian cell line to grow avian and animal viruses to produce vaccines
WO1997046103A1 (en) * 1996-06-04 1997-12-11 University Of Georgia Research Foundation, Inc. Modified live avian polyomavirus vaccine in psittacine birds
EP1038952A3 (en) * 1998-12-09 2001-06-27 Pfizer Products Inc. Processes for preparation of Marek's Disease Virus using continuous avian cell lines
AP2014007955A0 (en) 2012-03-22 2014-09-30 Merial Ltd Modified marek's disease virus, and vaccines made therefrom

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1292803A (en) * 1968-11-18 1972-10-11 Nat Res Dev Improvements relating to the production of antigens
US3642574A (en) * 1970-04-29 1972-02-15 Us Agriculture Method for producing vaccine for immunization of poultry against marek{3 s disease
US3783098A (en) * 1971-08-10 1974-01-01 Cornell Res Foundation Inc Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same
US4160024A (en) * 1978-05-01 1979-07-03 Cornell Research Foundation, Inc. Marek's disease vaccine

Also Published As

Publication number Publication date
IL74809A (en) 1990-09-17
EP0159743A1 (en) 1985-10-30
IL74809A0 (en) 1985-07-31
YU59985A (en) 1988-06-30
HUT38542A (en) 1986-06-30
IN163229B (es) 1988-08-27
NL8401120A (nl) 1985-11-01
YU44687B (en) 1990-12-31
ATE56364T1 (de) 1990-09-15
ES541930A0 (es) 1986-04-16
ZA852564B (en) 1985-11-27
DE3579617D1 (de) 1990-10-18
JPS6123A (ja) 1986-01-06
ES8605680A1 (es) 1986-04-16
CA1251397A (en) 1989-03-21
EP0159743B1 (en) 1990-09-12
WO1985004588A1 (en) 1985-10-24
US4673572A (en) 1987-06-16
AU4156185A (en) 1985-11-01
MX7718E (es) 1990-10-10
JPH0317808B2 (es) 1991-03-11
HU194496B (en) 1988-02-29
AU574164B2 (en) 1988-06-30

Similar Documents

Publication Publication Date Title
DE69637251T2 (de) Kultivierung von Lawsonia intracellularis, Impfstoffe gegen Lawsonia intracellularis und diagnostische Mittel
DE69732407T2 (de) Verfahren für die replikation von influenza in zellkultur und die bei diesem verfahren hergestellten influenza-viren
DD232822A5 (de) Verfahren zur herstellung eines viruspraeparates gegen die mareksche gefluegelkrankheit
DE2708668A1 (de) Nd-impfstoff und verfahren zu seiner herstellung
DE2713371C2 (es)
DE69216732T2 (de) Impfstoff gegen den Geflügelanämieerreger
DE2516274A1 (de) Stark abgeschaechter megalozytenvirusimpfstoff und dessen herstellung
DE2817891A1 (de) Nd-impfstoff und verfahren zu seiner herstellung
DE1957747A1 (de) Impfstoffe und Verfahren zu ihrer Herstellung
DE69730040T2 (de) In ovo impfung gegen die newcastle-krankheit
CH658192A5 (de) Tollwut-impfstoff und verfahren zu seiner herstellung.
DE69103130T2 (de) Zellfreies Marekskrankheitvirus-Vakzin.
DE1198489B (de) Verfahren zur Herstellung eines Impfstoffes gegen Panleucopenie
DE2843295C2 (es)
DE68920345T2 (de) Lebendes Kombinationsvakzin.
DE3878982T2 (de) Abgeschwaechtes virus und impfstoffe davon zur verwendung gegen infektionen bei gefluegel, verursacht durch truthahn-rhinotracheitis-virus.
DE69835346T2 (de) Vakzine gegen infektiöse bursitis
EP0312839A2 (de) Verfahren zur Herstellung von Paramunitätsinducern
DE60114908T2 (de) Hühner-Anäemie-Virus mit geringer Pathogenität
Mussgay et al. Studies with a pathogenic and an attenuated strain of Venezuelan equine encephalitis virus and Aedes aegypti (L.) mosquitoes
Oei et al. Comparison of intramuscular and subcutaneous administration of Marek's disease vaccine
DE2165401C3 (de) Inaktivierter Kombinationsimpfstoff zum Immunisieren von Geflügel gegen Infektion der Atmungsorgane
DE2415353A1 (de) Verfahren zur herstellung von temperaturempfindlichen, nicht pathogenen mutanten von herpes simplex typ 2-viren und ihre verwendung zur herstellung von vaccinen
DE3136430C2 (es)
Koyama et al. The relationship between feathering abnormalities (“nakanuke”) and tumour production in chickens inoculated with reticuloendotheliosis virus

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee